Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please turn on Javascript support in your web browser and reload ...
Aims: The aim of this study was to develop and validate a prognostic model based on clinical laboratory biomarkers for the early identification of high-risk patients who require intensive care unit ...
Pfizer, Inc. stock has fallen nearly 60% from its peak in December 2021. Could a turnaround be near? In a promising sign, Pfizer has announced its 14th consecutive annual dividend increase, signaling ...
Experts say the end of the coronavirus pandemic state of emergency could have a big impact on those of us who may have gotten used to having access to certain COVID-related health benefits. Here's ...
At least 7,924 new coronavirus cases were reported in North Carolina last week, down from 8,604 the week before, according to preliminary data from state health officials. The N.C. Department of ...
Pfizer’s antiviral COVID-19 pill Paxlovid can protect against long COVID symptoms, a study says. Stephanie Nano AP New findings suggest Pfizer’s COVID-19 pill Paxlovid may offer protection against ...
Wondering if the COVID nightmare will ever end? “Our COVID-19 franchises will remain multibillion-dollar revenue generators for the forseeable future,” Pfizer chairman and chief executive officer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback